Cargando…

Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses

Amid controversial reports that COVID-19 can be treated with a combination of the antimalarial drug hydroxychloroquine (HCQ) and the antibiotic azithromycin (AZI), a clinical trial (ONCOCOVID, NCT04341207) was launched at Gustave Roussy Cancer Campus to investigate the utility of this combination th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Peng, Zhao, Liwei, Ferrere, Gladys, Alves-Costa-Silva, Carolina, Ly, Pierre, Wu, Qi, Tian, Ai-Ling, Derosa, Lisa, Zitvogel, Laurence, Kepp, Oliver, Kroemer, Guido
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458592/ https://www.ncbi.nlm.nih.gov/pubmed/32923151 http://dx.doi.org/10.1080/2162402X.2020.1789284

Ejemplares similares

Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response
por: Tian, Ai-Ling, et al.
Publicado: (2021)

Lurbinectedin: an FDA-approved inducer of immunogenic cell death for the treatment of small-cell lung cancer
por: Kepp, Oliver, et al.
Publicado: (2020)

Prevention and treatment of cancers by tumor antigen-expressing Staphylococcus epidermidis
por: Kepp, Oliver, et al.
Publicado: (2023)

Secreted calreticulin mutants subvert anticancer immunosurveillance
por: Liu, Peng, et al.
Publicado: (2019)

An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
por: Senovilla, Laura, et al.
Publicado: (2013)

Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress
por: Michaud, Mickaël, et al.
Publicado: (2014)

Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2013)

Trial watch: Peptide-based vaccines in anticancer therapy
por: Bezu, Lucillia, et al.
Publicado: (2018)

Tumor-infiltrating lymphocytes for melanoma immunotherapy
por: Kepp, Oliver, et al.
Publicado: (2023)

Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade
por: Ferrere, Gladys, et al.
Publicado: (2021)

PD-1 blockade synergizes with oxaliplatin-based, but not cisplatin-based, chemotherapy of gastric cancer
por: Liu, Peng, et al.
Publicado: (2022)

Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021)

Immunogenic cell death inducers as anticancer agents
por: Kepp, Oliver, et al.
Publicado: (2014)

Ferroptosis becomes immunogenic: implications for anticancer treatments
por: Tang, Daolin, et al.
Publicado: (2020)

A genotype-phenotype screening system using conditionally immortalized immature dendritic cells
por: Zhao, Liwei, et al.
Publicado: (2021)

Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors
por: Daillère, Romain, et al.
Publicado: (2020)

Trial Watch: combination of tyrosine kinase inhibitors (TKIs) and immunotherapy
por: Petrazzuolo, Adriana, et al.
Publicado: (2022)

Immunostimulatory effects of vitamin B5 improve anticancer immunotherapy
por: Bourgin, Melanie, et al.
Publicado: (2022)

COVID-19: a challenge for oncology services
por: Routy, Bertrand, et al.
Publicado: (2020)

Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
por: Zhang, Shuai, et al.
Publicado: (2023)

Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects
por: Kepp, Oliver, et al.
Publicado: (2012)

A mitochondrial checkpoint to adaptive anticancer immunity
por: Kepp, Oliver, et al.
Publicado: (2023)

AKT as a therapeutic target for autophagy induction and cancer therapy
por: Wu, Qi, et al.
Publicado: (2021)

Trial watch: dietary interventions for cancer therapy
por: Lévesque, Sarah, et al.
Publicado: (2019)

Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2014)

The intimate relationship between gut microbiota and cancer immunotherapy
por: Elkrief, Arielle, et al.
Publicado: (2018)

Oral administration of Akkermansia muciniphila elevates systemic antiaging and anticancer metabolites
por: Grajeda-Iglesias, Claudia, et al.
Publicado: (2021)

Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020)

Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)

ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2013)

Trial watch: Cardiac glycosides and cancer therapy
por: Menger, Laurie, et al.
Publicado: (2013)

Conventional type 1 dendritic cells (cDC1) in cancer immunity
por: Liu, Peng, et al.
Publicado: (2023)

Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
por: Michaud, Mickaël, et al.
Publicado: (2012)

Trial Watch: Anticancer radioimmunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

QT interval prolongation with hydroxychloroquine plus azithromycin
Publicado: (2020)

Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin
por: Derendorf, Hartmut
Publicado: (2020)

Hydroxychloroquine-azithromycin for COVID-19 – Warranted or dangerous?
por: Popescu, Corneliu P., et al.
Publicado: (2020)

Hydroxychloroquine and azithromycin as a treatment of COVID-19
por: Fanin, Alice, et al.
Publicado: (2020)

An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy
por: Michaud, Mickaël, et al.
Publicado: (2014)

Author Correction: The immuno-oncological challenge of COVID-19
por: Derosa, Lisa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ea22sq4hg2ko09af0ljc28b4b2